COVID-19: Risk for Cytokine Targeting in Chronic Inflammatory Diseases?

Nature Reviews Immunology - United Kingdom
doi 10.1038/s41577-020-0312-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

On the Alert for Cytokine Storm: Immunopathology in COVID-19

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2020English

COVID-19 in Children and Altered Inflammatory Responses

Pediatric Research
Child HealthPediatricsPerinatology
2020English

Thoughts on COVID-19 and Autoimmune Diseases

Lupus Science and Medicine
MedicineImmunology
2020English

Risk-Adapted Treatment Strategy for COVID-19 Patients

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2020English

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in COVID-19 Patient

Disaster and Emergency Medicine Journal
2020English

Non-Steroidal Anti-Inflammatory Drugs and Covid-19

British Medical Journal
Medicine
2020English

Waiting for COVID-19

Journal of Paediatrics and Child Health
Child HealthPediatricsPerinatology
2020English

Changes of the Cytokine Profile in Inflammatory Bowel Diseases

World Journal of Gastroenterology
MedicineGastroenterology
2012English

Arterial Stiffness in Chronic Inflammatory Diseases

Hypertension
Internal Medicine
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy